Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Cancers|July 2, 2021
Impact of High-Dose Methotrexate on the Outcome of Patients with Diffuse Large B-Cell Lymphoma and Skeletal InvolvementMélanie Mercier, Corentin Orvain, Laurianne Drieu La Rochelle, et al.
The Journal of Molecular Diagnostics : JMD|August 25, 2024
Tailored Digital PCR Follow-Up of Rare Fusion Transcripts after Initial Detection through RNA Sequencing in Hematological MalignanciesMarie-Laure Boulland, Amyra Aliouat, Elie Jalaber, et al.
Cancer Medicine|November 26, 2020
Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT)Francesco Saraceni, Myriam Labopin, Edouard Forcade, et al.
Oncogene|May 23, 2026
Signals from the bone marrow B cell niches shape pre-leukemic fate in a murine model of B cell acute lymphoblastic leukemiaMarjorie C Delahaye, Simon Léonard, Jeoffrey Pelletier, et al.
Haematologica|July 21, 2018
Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL groupLionel Adès, Xavier Thomas, Agnes Guerci Bresler, et al.
Transplantation|November 4, 2015
Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie CellulaireAurelie Ravinet, Aurelie Cabrespine, Gerard Socié, et al.
Annals of Hematology|June 22, 2020
Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TCAmandine Le Bourgeois, Myriam Labopin, Ambroise Marçais, et al.
JAMA Oncology|February 3, 2018
Comparison of the Hemostatic Efficacy of Pathogen-Reduced Platelets vs Untreated Platelets in Patients With Thrombocytopenia and Malignant Hematologic Diseases: A Randomized Clinical TrialFrédéric Garban, Audrey Guyard, Helene Labussière, et al.
Annals of Hematology|April 11, 2023
Outcome of patients with newly diagnosed AML admitted to the ICU, including preemptive admission - a multi-center studyChristophe Desprez, Achille Kouatchet, Tony Marchand, et al.
Iscience|April 3, 2023
Niche-expressed Galectin-1 is involved in pre-B acute lymphoblastic leukemia relapse through pre-B cell receptor activationJeoffrey Pelletier, Marielle Balzano, Jérôme Destin, et al.
Pageof 6